Market Cap : 6.71 B | Enterprise Value : 9.88 B | PE Ratio : 24.78 | PB Ratio : 2.04 |
---|
NAS:SYNH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SYNH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Syneos Health's earnings per share without non-recurring items for the three months ended in Jun. 2022 was $0.75. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was $2.66.
During the past 12 months, Syneos Health's average earnings per share (NRI) Growth Rate was 18.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 113.60% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Syneos Health's EPS without NRI or its related term are showing as below:
During the past 11 years, Syneos Health's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 113.60% per year. The lowest was -53.70% per year. And the median was -14.90% per year.
Syneos Health's EPS (Diluted) for the three months ended in Jun. 2022 was $0.75. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $2.66.
Syneos Health's EPS (Basic) for the three months ended in Jun. 2022 was $0.76. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was $2.70.
The historical data trend for Syneos Health's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Syneos Health's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's EPS without NRI distribution charts can be found below:
* The bar in red indicates where Syneos Health's EPS without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Syneos Health's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.
Zulueta Alfonso G | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Bodem Barbara W. | director | C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Brooks Michael Lee | officer: See remarks | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Wilkes David S. | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Connaughton Bernadette | director | C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139 |
Klitgaard William E | director | 210 CARNEGIE CENTER PRINCETON NJ 08540 |
Meyers Kenneth F | director | 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 |
Monaghan Matthew E. | director | ONE INVACARE WAY ELYRIA OH 44035 |
Harty Linda S | director | MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432 |
Kralowetz Donna Hildebrand | officer: SVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Colvin Paul | officer: Pres., Clinical Solutions | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Parks Robert | officer: EVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Olefson Jonathan | officer: General Counsel & Corp Secty | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Meggs Jason M. | officer: Chief Financial Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Gpe Vii Gp S.a.r.l. | 10 percent owner | CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199 |
From GuruFocus
By GlobeNewswire 09-14-2021
By Marketwired 10-06-2021
Other Sources
By Zacks 2022-03-10
By Zacks 2021-11-23
By Zacks 2022-02-18
By Seekingalpha 2022-02-17
By Seekingalpha 2021-11-03
By Zacks 2022-03-29
By Zacks 2021-09-29
By Zacks 2021-08-10
By Zacks 2021-10-13
By Zacks 2021-09-10
By Zacks 2021-12-03
By Zacks 2021-12-23